A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer
Clinical trial NCT04194554 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04194554
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-06
- Primary completion
- 2027-05-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.